AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32410198 — intervention group
Group type: EXPERIMENTAL
Intervention: Camouflage of the dorsum by diced cartilage
Number of subjects: 101
Study 32410198 — intervention group
Group type: EXPERIMENTAL
Intervention: Camouflage of the dorsum with lipofilling
Number of subjects: 101
Study 32410198 — intervention group
Group type: EXPERIMENTAL
Intervention: Camouflage of the dorsum by a temporal fascia graft
Number of subjects: 101
Study 32410198 — intervention group
Group type: COMPARATOR
Intervention: Without camouflage of the dorsum (control group)
Number of subjects: 101
Study 32598752 — intervention group
Group type: EXPERIMENTAL
Intervention: rabeprazole 40 mg
Number of subjects: 89
Study 32598752 — intervention group
Group type: EXPERIMENTAL
Intervention: rabeprazole 20 mg
Number of subjects: 89
Study 32598752 — intervention group
Group type: COMPARATOR
Intervention: standard dose rabeprazole
Number of subjects: 89
Study 32598752 — intervention group
Group type: COMPARATOR
Intervention: CYP2C19 metabolizers (ultrarapid, rapid, normal, intermediate)
Number of subjects: 89
Study 32598752 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐1β CC genotype
Number of subjects: 89
Study 32598752 — intervention group
Group type: EXPERIMENTAL
Intervention: MDR1 TT genotype
Number of subjects: 89
Study 34767728 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive interpersonal relationships (siblings, grandparents, teachers, friends' parents)
Number of subjects: 33
Study 34767728 — intervention group
Group type: EXPERIMENTAL
Intervention: Discouragement from conflicting rules and social comparison
Number of subjects: 33
Study 34963300 — intervention group
Group type: EXPERIMENTAL
Intervention: Target LDL cholesterol of <70 mg/dL
Number of subjects: 2860
Study 34963300 — intervention group
Group type: COMPARATOR
Intervention: Target LDL cholesterol of 100±10 mg/dL
Number of subjects: 2860
Study 35543211 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Intervention (MBI) for 8 weeks
Number of subjects: 19
Study 35543211 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 19
Study 35543211 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Intervention (MBI)
Number of subjects: 19
Study 32510573 — intervention group
Group type: EXPERIMENTAL
Intervention: HidroQoL© intervention
Number of subjects: 171
Study 32510573 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 171
Study 33107841 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive term-time workers (female)
Number of subjects: 2800
Study 33107841 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate term-time workers
Number of subjects: 2800
Study 33107841 — intervention group
Group type: COMPARATOR
Intervention: Non term-time workers (female)
Number of subjects: 2800
Study 33107841 — intervention group
Group type: EXPERIMENTAL
Intervention: Term-time workers (13-15 years old)
Number of subjects: 2800
Study 33107841 — intervention group
Group type: EXPERIMENTAL
Intervention: Term-time workers (financially well-off families)
Number of subjects: 2800
Study 34623761 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of perioperative antibiotics (piperacillin + tazobactam - 4.5 g intravenous at fixed 8 hourly intervals)
Number of subjects: 126
Study 34623761 — intervention group
Group type: COMPARATOR
Intervention: Nine doses of perioperative antibiotics (piperacillin + tazobactam - 4.5 g intravenous at fixed 8 hourly intervals)
Number of subjects: 126
Study 34623761 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of perioperative antibiotics
Number of subjects: 126
Study 34623761 — intervention group
Group type: COMPARATOR
Intervention: Nine doses of perioperative antibiotics
Number of subjects: 126
Study 34350669 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted mental health experience codesign intervention
Number of subjects: 287
Study 34350669 — intervention group
Group type: COMPARATOR
Intervention: Control phase
Number of subjects: 287
Study 32543979 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 0
Study 35577410 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 4 months
Number of subjects: 193
Study 35577410 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 193
Study 32907392 — intervention group
Group type: EXPERIMENTAL
Intervention: Domiciliary program of oculomotor and gaze stability exercises for three weeks
Number of subjects: 68
Study 32907392 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard rehabilitation program)
Number of subjects: 68
Study 34492326 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile gloves (modified sterile technique: only sterile gloves)
Number of subjects: 530
Study 34492326 — intervention group
Group type: COMPARATOR
Intervention: Clean technique (usual care with non-sterile gloves)
Number of subjects: 530
Study 34492326 — intervention group
Group type: COMPARATOR
Intervention: Baseline period (before intervention)
Number of subjects: 530
Study 34492326 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention period (after intervention)
Number of subjects: 530
Study 33491287 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (GT) and resistance training (RT)
Number of subjects: 44
Study 33491287 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 44
Study 33491287 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 44
Study 35439530 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy
Number of subjects: 207
Study 35439530 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy with uterosacral ligament suspension
Number of subjects: 207
Study 35439530 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative Pelvic Organ Prolapse Quantification stage 3 or 4
Number of subjects: 207
Study 32195897 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid escalation to enteral nutrition reaching goal feeds by 27 hours
Number of subjects: 50
Study 32195897 — intervention group
Group type: COMPARATOR
Intervention: Standard feeding practice reaching goal feeds by 63 hours
Number of subjects: 50
Study 32195897 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid escalation to enteral nutrition
Number of subjects: 50
Study 32195897 — intervention group
Group type: COMPARATOR
Intervention: Standard feeding practice
Number of subjects: 50
Study 35500476 — intervention group
Group type: EXPERIMENTAL
Intervention: New room (birthing room designed with person‐centred considerations)
Number of subjects: 406
Study 35500476 — intervention group
Group type: COMPARATOR
Intervention: Regular room
Number of subjects: 406
Study 35500476 — intervention group
Group type: EXPERIMENTAL
Intervention: New room
Number of subjects: 406
Study 34881909 — intervention group
Group type: EXPERIMENTAL
Intervention: Competence feedback group (CFG)
Number of subjects: 114
Study 34881909 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 114
Study 32740291 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncaloric placebo (PLA)
Number of subjects: 36
Study 32740291 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.4% maltodextrin (CHO) solution
Number of subjects: 36
Study 32740291 — intervention group
Group type: COMPARATOR
Intervention: Water (WAT)
Number of subjects: 36
Study 32740291 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (WAT, PLA, CHO)
Number of subjects: 36
Study 33296380 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating sphingolipids (specifically ceramides and sphingomyelins)
Number of subjects: 1974
Study 33296380 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated sphingomyelins
Number of subjects: 1974
Study 33296380 — intervention group
Group type: EXPERIMENTAL
Intervention: 13 sphingolipids
Number of subjects: 1974
Study 33296380 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically instrumented ceramide (d18:1/20:1)
Number of subjects: 1974
Study 35748295 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected insulin response (CIR)
Number of subjects: 0
Study 33141785 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance/Movement Therapy (DMT)
Number of subjects: 32
Study 33141785 — intervention group
Group type: COMPARATOR
Intervention: Verbal Treatment as Usual (TAU)
Number of subjects: 32
Study 32427935 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic exercise (ID) program
Number of subjects: 46
Study 32427935 — intervention group
Group type: COMPARATOR
Intervention: Home-based (HB) exercise program
Number of subjects: 46
Study 35593501 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavone supplementation (single oral tablet of soy extract for 30 days)
Number of subjects: 15
Study 35593501 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol treatment (0.5 μg subcutaneous injection in sesame oil for 30 days)
Number of subjects: 15
Study 35593501 — intervention group
Group type: COMPARATOR
Intervention: Control (subcutaneous injections of vehicle and oral placebo for 30 days)
Number of subjects: 15
Study 33374975 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk-based infant formula with micronutrients and PUFAs
Number of subjects: 2
Study 33374975 — intervention group
Group type: COMPARATOR
Intervention: Milk-based infant formula with micronutrients, no PUFAs added
Number of subjects: 2
Study 36422887 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental messages (31 total, including 25 experimental and 6 control messages)
Number of subjects: 189
Study 36422887 — intervention group
Group type: COMPARATOR
Intervention: Control messages (6 total)
Number of subjects: 189
Study 36422887 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental messages (themes 2-5)
Number of subjects: 189
Study 36422887 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages providing scientific evidence from credible sources
Number of subjects: 189
Study 33269417 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 143
Study 33269417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 32074780 — intervention group
Group type: EXPERIMENTAL
Intervention: Dural puncture epidural group (group D)
Number of subjects: 100
Study 32074780 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia group (group P)
Number of subjects: 100
Study 36259428 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar transcranial direct current stimulation (tDCS)
Number of subjects: 20
Study 36259428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34724345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolebrutinib 5 mg
Number of subjects: 38
Study 34724345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolebrutinib 15 mg
Number of subjects: 38
Study 34724345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolebrutinib 30 mg
Number of subjects: 38
Study 34724345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolebrutinib 60 mg
Number of subjects: 38
Study 34724345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolebrutinib 120 mg
Number of subjects: 38
Study 34724345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolebrutinib 7.5 mg (multiple ascending dose)
Number of subjects: 38
Study 34724345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolebrutinib 15 mg (multiple ascending dose)
Number of subjects: 38
Study 34724345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolebrutinib 30 mg (multiple ascending dose)
Number of subjects: 38
Study 34724345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolebrutinib 60 mg (multiple ascending dose)
Number of subjects: 38
Study 34724345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolebrutinib 90 mg (multiple ascending dose)
Number of subjects: 38
Study 34724345 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 33475318 — intervention group
Group type: EXPERIMENTAL
Intervention: CT model
Number of subjects: 200
Study 33475318 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomic model
Number of subjects: 200
Study 33475318 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination model
Number of subjects: 200
Study 33475318 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on combination model
Number of subjects: 200
Study 32789987 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person experience (Live Animal) viewing a polar bear training session for 10 minutes
Number of subjects: 124
Study 32789987 — intervention group
Group type: EXPERIMENTAL
Intervention: Video experience (Video Animal) watching a video of the polar bear training session
Number of subjects: 124
Study 32789987 — intervention group
Group type: COMPARATOR
Intervention: Control group (Control) listening to audio from the live experience while viewing an image of an animal care specialist
Number of subjects: 124
Study 35853583 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin use for induction of labor
Number of subjects: 941
Study 35853583 — intervention group
Group type: EXPERIMENTAL
Intervention: Cesarean delivery
Number of subjects: 941
Study 32919897 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided dextrose prolotherapy (2 cc dextrose 20% injection, 2 sessions)
Number of subjects: 59
Study 32919897 — intervention group
Group type: COMPARATOR
Intervention: Radial extracorporeal shock wave therapy (ESWT, 3 sessions)
Number of subjects: 59
Study 32571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Task (ST)
Number of subjects: 40
Study 32571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal Dual-Task (DT)
Number of subjects: 40
Study 32571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory Dual-Task (DT)
Number of subjects: 40
Study 32571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Dual-Task (DT)
Number of subjects: 40
Study 32571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Dual-Task (DT)
Number of subjects: 40
Study 32571284 — intervention group
Group type: COMPARATOR
Intervention: Healthy Group (HG)
Number of subjects: 40
Study 33973838 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray and white matter involvement
Number of subjects: 1026
Study 33973838 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticospinal tract involvement
Number of subjects: 1026
Study 33973838 — intervention group
Group type: EXPERIMENTAL
Intervention: Territorial infarcts
Number of subjects: 1026
Study 33973838 — intervention group
Group type: EXPERIMENTAL
Intervention: Infarct confinement to gray matter, corticospinal tract sparing, and scattered infarct structure
Number of subjects: 1026
Study 32719096 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1605
Study 32719096 — intervention group
Group type: COMPARATOR
Intervention: Intensive medical therapy (IMT)
Number of subjects: 1605
Study 32719096 — intervention group
Group type: EXPERIMENTAL
Intervention: Random deferral of PCI (simulated)
Number of subjects: 1605
Study 35681620 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (10 mg QD)
Number of subjects: 42
Study 35681620 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide-LAR (60 mg Q4 weeks)
Number of subjects: 42
Study 35681620 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Everolimus and Pasireotide-LAR
Number of subjects: 42
Study 32525975 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive strength training with elastic resistance (2 days per week for 8 weeks)
Number of subjects: 20
Study 32525975 — intervention group
Group type: COMPARATOR
Intervention: Usual daily activities
Number of subjects: 20
Study 35086041 — intervention group
Group type: EXPERIMENTAL
Intervention: 200-ppb ozone exposure for 2 hours
Number of subjects: 32
Study 33428870 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 + 1 schedule of the 13-valent pneumococcal conjugate vaccine (PCV13) with 4CMenB at 2, 4, and 12 months of age.
Number of subjects: 213
Study 33428870 — intervention group
Group type: COMPARATOR
Intervention: 1 + 1 schedule of the 13-valent pneumococcal conjugate vaccine (PCV13) with 4CMenB at 3 and 12 months of age.
Number of subjects: 213
Study 35877183 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal soft contact lenses (MFSCLs)
Number of subjects: 66
Study 35877183 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology contact lenses (Ortho-kCLs)
Number of subjects: 66
Study 35877183 — intervention group
Group type: COMPARATOR
Intervention: Single vision spectacles (SVSs)
Number of subjects: 66
Study 34135111 — intervention group
Group type: COMPARATOR
Intervention: Daily energy restriction (75:75)
Number of subjects: 36
Study 34135111 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting (0:150)
Number of subjects: 36
Study 34135111 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting without energy restriction (0:200)
Number of subjects: 36
Study 34135111 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 36
Study 32087394 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator-based high order training program
Number of subjects: 183
Study 32087394 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting group)
Number of subjects: 183
Study 35792962 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g amoxicillin administered 1 hour before surgery, followed by 1.5 g each for the first 3 postoperative days
Number of subjects: 0
Study 35792962 — intervention group
Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 0
Study 34011108 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial release (3 sessions of 50 minutes over 3 weeks)
Number of subjects: 69
Study 34011108 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 69
Study 36200390 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded Intervention (Delaware PEAK) - five 45- to 60-minute video conference-based sessions of supervised exercise delivered over 12 weeks by a physical therapist.
Number of subjects: 100
Study 36200390 — intervention group
Group type: COMPARATOR
Intervention: Brief Intervention (control group) - a website with prerecorded videos directing participants to web-based resources for strengthening, physical activity, and pain management for knee OA.
Number of subjects: 100
Study 33534047 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 64
Study 33534047 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 40 mg bid for 3 days followed by 20 mg bid for 3 days
Number of subjects: 64
Study 32155883 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (1250 mg daily for 12 weeks)
Number of subjects: 31
Study 32155883 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 31
Study 32155883 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy controls with DHA
Number of subjects: 31
Study 35511621 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual reduction (Group A)
Number of subjects: 202
Study 35511621 — intervention group
Group type: COMPARATOR
Intervention: Automatic device reduction (Group B)
Number of subjects: 202
Study 32394655 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (tongdu jiangni needling technique), 3 times a week for 8 weeks
Number of subjects: 60
Study 32394655 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole enteric capsules (OME), 20 mg twice a day for 8 weeks
Number of subjects: 60
Study 34932889 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet+Incentives
Number of subjects: 418
Study 34932889 — intervention group
Group type: COMPARATOR
Intervention: Internet-Only
Number of subjects: 418
Study 33707523 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMan mobile personal health system
Number of subjects: 56
Study 33707523 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 36065641 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbatim repetition
Number of subjects: 46
Study 36065641 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomorphic changes
Number of subjects: 46
Study 36065641 — intervention group
Group type: EXPERIMENTAL
Intervention: Total revisions
Number of subjects: 46
Study 33561214 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ-LNS (800 μg RE/20g) during pregnancy and the first 6 mo postpartum; children received SQ-LNS (400 μg RE/20 g) from 6 to 18 mo of age.
Number of subjects: 0
Study 33561214 — intervention group
Group type: COMPARATOR
Intervention: Multiple micronutrients (MMN; 800 μg retinol equivalent (RE)/capsule) during pregnancy only.
Number of subjects: 0
Study 33561214 — intervention group
Group type: COMPARATOR
Intervention: Iron and folic acid (IFA) during pregnancy only.
Number of subjects: 0
Study 33561214 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ-LNS (400 μg RE/20 g) for children from 6 to 18 mo of age.
Number of subjects: 0
Study 33561214 — intervention group
Group type: COMPARATOR
Intervention: Multiple micronutrients (MMN) and Iron and folic acid (IFA) for children (no supplement).
Number of subjects: 0
Study 32613240 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologic E2 (∼180 pg/ml) with P4 10 mg/day
Number of subjects: 10
Study 32613240 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately supraphysiologic E2 (600-800 pg/ml) with P4 10 mg/day
Number of subjects: 10
Study 32613240 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraphysiologic E2 (2000 pg/ml) with P4 10 mg/day
Number of subjects: 10
Study 34996663 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-borne expander (hyrax)
Number of subjects: 36
Study 34996663 — intervention group
Group type: COMPARATOR
Intervention: Bone-borne expander (computer-guided miniscrew-supported)
Number of subjects: 36
Study 33766497 — intervention group
Group type: EXPERIMENTAL
Intervention: BH4 treatment
Number of subjects: 11
Study 33766497 — intervention group
Group type: COMPARATOR
Intervention: Diet only (without BH4)
Number of subjects: 11
Study 34214362 — intervention group
Group type: EXPERIMENTAL
Intervention: Centella asiatica cream applied twice a day
Number of subjects: 30
Study 34214362 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramide cream applied twice a day
Number of subjects: 30
Study 32556156 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic Retinopexy (PnR)
Number of subjects: 160
Study 34939269 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (received intervention immediately)
Number of subjects: 52